Coapt Systems

About:

Coapt Systems develops bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures.

Website: http://www.coaptsystems.com

Top Investors: Canaan Partners, Asset Management Ventures (AMV), Alta Partners, Boston Millennia Partners, Easton Capital

Description:

Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilization trays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.

Total Funding Amount:

$58M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2000-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2009-12-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai